Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Monoclonal antibodies
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Dual-Parameter Immunoflow Cytometry – A New Technique in the Noninvasive Diagnosis of Bladder Cancer
Available to PurchaseSubject Area:
Further Areas
Feliksas Jankevicius, Taro Shibayama, Klaus Decken, Hans Bojar, Thomas Ebert, Rolf Ackermann, Bernd J. Schmitz-Dräger
Journal:
Urologia Internationalis
Urol Int (1995) 55 (2): 68–73.
Published Online: 03 February 2010
...Feliksas Jankevicius; Taro Shibayama; Klaus Decken; Hans Bojar; Thomas Ebert; Rolf Ackermann; Bernd J. Schmitz-Dräger The introduction of monoclonal antibodies into the diagnosis of transitional cell carcinoma (TCC) has been a further step toward the use of biological parameters to support...
Journal Articles
Failure of Cytotoxic Chemotherapy, 1983–1988, and the Emerging Role of Monoclonal Antibodies for Renal Cancer
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1989) 44 (6): 338–345.
Published Online: 29 January 2010
...Alan Yagoda; Neil H. Bander A review of 36 cytotoxic agents used singly in over 1,900 patients with renal cancer between 1983 and 1988 finds marginal antitumor activity, < 5–10%. The future role of monoclonal antibodies for therapy of this disease may offer some hope with the recent description...